Your session is about to expire
← Back to Search
TMS Brain Signal Measurement in Healthy Subjects
N/A
Recruiting
Led By David J Levinthal, MD PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up multiple study sessions spanning up to 12 months
Awards & highlights
Study Summary
This trial studies how to non-invasively measure brain signals in the stomach using magnetic stimulation and brain signals.
Who is the study for?
This trial is for healthy individuals interested in participating in a study to understand how the brain can influence stomach functions. Specific eligibility criteria are not provided, but typically participants should be free from any medical conditions that could interfere with the study.Check my eligibility
What is being tested?
The study is testing a non-invasive brain stimulation technique called Transcranial Magnetic Stimulation (TMS) to see how it affects signals going to the stomach. The goal is to find out the best settings and areas of the brain to use for this method.See study design
What are the potential side effects?
TMS may cause mild headaches or scalp discomfort at the site of stimulation, lightheadedness, or tingling sensations. It's generally considered safe with no serious side effects when performed correctly.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ multiple study sessions spanning up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~multiple study sessions spanning up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in GEP hotspot location
Change in optimal stimulation parameters at GEP hotspot
Secondary outcome measures
Effect of neuromodulation
Effect of satiety
Trial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
All participants
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,343,001 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,434 Total Patients Enrolled
David J Levinthal, MD PhDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
110 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of head injury, stroke, seizures, or fainting.I have diabetes.I have had weight loss surgery, like sleeve gastrectomy or gastric bypass.I am not taking any seizure-inducing drugs or consuming three or more alcoholic drinks daily.I have a condition that is causing my nerves to deteriorate over time.
Research Study Groups:
This trial has the following groups:- Group 1: All participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this experiment accommodate participants who exceed the age of twenty?
"This research project is inviting volunteers aged 21 and older but younger than 60 to participate."
Answered by AI
Is enrollment open to the public for this clinical experiment?
"According to clinicaltrials.gov, this particular medical study has ended its participant search after being posted on July 1st 2023 and last updated on June 26th 2023. Fortunately, there are 792 other trials that are still taking in applicants at the moment."
Answered by AI
For whom is this study most appropriate?
"Eligible candidates for this clinical trial must be aged between 21 and 60, have no medical complications, and be one of the total 155 openings."
Answered by AI
Share this study with friends
Copy Link
Messenger